Position in SCLX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$159
-$133 QoQ
Shares Held
24
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NFSG Corp holds $11,035,406 across 16 Drug Manufacturers - General names. SCLX ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,184 | $4,768,087 | |
| 2 | ABBV |
AbbVie Inc.
|
8,735 | $1,899,775 | |
| 3 | JNJ |
Johnson & Johnson
|
7,319 | $1,789,056 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
7,909 | $1,102,277 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,911 | $350,164 | |
| 6 | PFE |
Pfizer Inc
|
11,084 | $311,238 | |
| 7 | GSK |
GSK plc
|
4,529 | $249,955 | |
| 8 | AMGN |
Amgen Inc
|
615 | $216,387 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $159 | 24 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $292 | 24 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $472 | 24 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $147 | 25 | Shares | Sole | 2025-08-19 | |
| No filing history on record for this holder in this stock. | ||||||